Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ravn

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|January 28, 1998
Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study GroupD Hosking, C E Chilvers, C Christiansen, et al.
Annals of Internal Medicine|February 21, 1998
Alendronate prevents postmenopausal bone loss in women without osteoporosis. A double-blind, randomized, controlled trial. Alendronate Osteoporosis Prevention Study GroupM McClung, B Clemmesen, A Daifotis, et al.
Annals of Internal Medicine|December 28, 1999
Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trialP Ravn, M Bidstrup, R D Wasnich, et al.
The European Respiratory Journal|December 2, 2010
Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patientsM G Aabye, M Ruhwald, G Praygod, et al.
Clinical Therapeutics|November 26, 1998
Evidence that increased calcium intake does not prevent early postmenopausal bone lossD J Hosking, P D Ross, D E Thompson, et al.
Electrophoresis|March 22, 2000
Identification of phage antibodies toward the Werner protein by selection on Western blotsP Ravn, S Kjaer, K H Jensen, et al.
The Journal of Clinical Endocrinology and Metabolism|April 19, 2000
Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study GroupP Ravn, S R Weiss, J A Rodriguez-Portales, et al.
The Journal of Infectious Diseases|February 10, 1999
Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosisP Ravn, A Demissie, T Eguale, et al.
The European Respiratory Journal|September 18, 2010
Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysisM Sester, G Sotgiu, C Lange, et al.
Radiography (London, England : 1995)|February 14, 2020
Comparison of image quality in chest, hip and pelvis examinations between mobile equipment in nursing homes and static indirect radiography equipment in the hospitalH Precht, D L Hansen, B M Ring-Pedersen, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|January 28, 1998
Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study GroupD Hosking, C E Chilvers, C Christiansen, et al.
Annals of Internal Medicine|February 21, 1998
Alendronate prevents postmenopausal bone loss in women without osteoporosis. A double-blind, randomized, controlled trial. Alendronate Osteoporosis Prevention Study GroupM McClung, B Clemmesen, A Daifotis, et al.
Annals of Internal Medicine|December 28, 1999
Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trialP Ravn, M Bidstrup, R D Wasnich, et al.
The European Respiratory Journal|December 2, 2010
Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patientsM G Aabye, M Ruhwald, G Praygod, et al.
Clinical Therapeutics|November 26, 1998
Evidence that increased calcium intake does not prevent early postmenopausal bone lossD J Hosking, P D Ross, D E Thompson, et al.
Electrophoresis|March 22, 2000
Identification of phage antibodies toward the Werner protein by selection on Western blotsP Ravn, S Kjaer, K H Jensen, et al.
The Journal of Clinical Endocrinology and Metabolism|April 19, 2000
Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study GroupP Ravn, S R Weiss, J A Rodriguez-Portales, et al.
The Journal of Infectious Diseases|February 10, 1999
Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosisP Ravn, A Demissie, T Eguale, et al.
The European Respiratory Journal|September 18, 2010
Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysisM Sester, G Sotgiu, C Lange, et al.
Radiography (London, England : 1995)|February 14, 2020
Comparison of image quality in chest, hip and pelvis examinations between mobile equipment in nursing homes and static indirect radiography equipment in the hospitalH Precht, D L Hansen, B M Ring-Pedersen, et al.
Pageof 9